Prenetics Global (PRENW) Current Deferred Revenue (2021 - 2026)

Prenetics Global has disclosed Current Deferred Revenue across 6 years of filings, most recently posting $2.9 million for Q1 2026.

• In Q1 2026, Current Deferred Revenue fell 52.21% year-over-year to $2.9 million; the TTM figure through Mar 2026 stood at $2.9 million (down 52.21% YoY), while the FY2025 annual figure was $3.1 million, down 52.46% from the prior year.
• Current Deferred Revenue slipped to $2.9 million in Q1 2026, from $3.1 million in the prior quarter.
• Over the last five years, Current Deferred Revenue for PRENW reached as high as $11.5 million in Q1 2022 and fell as low as $2.9 million in Q1 2026.
• The 5-year median for Current Deferred Revenue is $5.7 million (2022), against an average of $5.9 million.
• Annual changes were most pronounced in 2023 — Current Deferred Revenue slumped 62.06% — and 2024, when it jumped 47.96%.
• A 5-year view of Current Deferred Revenue shows it stood at $5.7 million in 2022, then climbed by 7.7% to $6.1 million in 2023, then increased by 6.22% to $6.5 million in 2024, then slumped by 52.46% to $3.1 million in 2025, then retreated by 4.47% to $2.9 million in 2026.
• According to Business Quant data, Current Deferred Revenue over the past three periods registered $2.9 million, $3.1 million, and $7.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.